This cohort study investigates the regulatory fate in the European Union for drugs that received accelerated approval for cancer indications in the US.

中文翻译：

---

癌症适应症在美国加速批准后在欧盟的监管命运


该队列研究调查了在美国获得加速癌症适应症批准的药物在欧盟的监管命运。